<DOC>
	<DOCNO>NCT00704574</DOCNO>
	<brief_summary>This observational study conduct Europe . The trial aim observe incidence serious adverse drug reaction child adolescent type 1 diabetes Levemir® treatment .</brief_summary>
	<brief_title>Observational Study Observe Safety Levemir® Treatment Children Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Informed consent obtain prior trialrelated activity Any patient diabetes type 1 eligible study , include newly The selection patient discretion individual physician Type 2 diabetes Currently treat Levemir®</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>